Industry Insights
Leading the Movement Towards Direct Cell Conversion: An Interview With Mogrify
Industry InsightTechnology Networks recently spoke with Joe Foster, COO, Mogrify, to learn about the biotech company's proprietary platform, the challenges encountered in developing cell therapies and to gain Mogrify's insights on the future of this exciting research space.
Read More
Looking to the Future of Cell and Gene Therapies
Industry InsightTechnology Networks recently spoke with three of the leaders in the cell and gene therapy space, Allogene Therapeutics, bluebird Bio and Mogrify to gain their insights on the next developments in this space.
Read More
Companion Diagnostic Will Support NSCLC Clinical Trials
Industry InsightTo learn more about some of the ways that companion diagnostics can benefit oncology patients, Technology Networks spoke to Dr Luca Quagliata, Global Director of Medical Affairs for Clinical NGS and Oncology at Thermo Fisher Scientific.
Further Analysis of SARS-CoV-2 Genome Suggests It Is Stable
Industry InsightTwo teams of scientists in Italy have collaborated on a project that further analyzed the SARS-CoV-2 genome from locally acquired samples. Technology Networks spoke with Professor Stefano Menzo, virologist, and Dr. Valerio Onofri, geneticist, affiliates of the Department of Excellence of Biomedical Science and Public Health, Marche Polytechnic University in Ancona, to learn more about the findings.
Using Fast-growing Tobacco Plants To Develop a COVID-19 Vaccine
Industry InsightTechnology Networks recently spoke to David O’Reilly, PhD, Director of Scientific Research at BAT to learn more about the tobacco plant “biomanufacturing factories” that are being used to develop a COVID-19 vaccine. We also discuss the challenges faced when developing a vaccine and the benefits tobacco plants offer compared to conventional vaccine development methods.
Read More
Developing Personalized Strategies To Maximize Cancer Therapy Success
Industry InsightTechnology Networks recently spoke with Ofer Sharon, CEO of OncoHost, to learn more about ways to overcome patient resistance to immunotherapy and how proteomic profiling in oncology can aid diagnosis, prognosis and treatment of this incredibly complex disease.
Read More
Developing Antibodies and Antigens for COVID-19 Diagnostics
Industry InsightTechnology Networks recently spoke to Dr Andy Lane, Commercial Director, The Native Antigen Company, to learn how SARS-CoV-2 antigens and antibodies can be used to drive the development of COVID-19 diagnostics.
Read More
Scaling Up Primer and Probe Kits for COVID-19 Testing
Industry InsightTechnology Networks spoke to Trey Martin, President, IDT, to find out exactly how primers and probes work, and learn about the important role they can play in COVID-19 testing.
Read More
Less Time Managing Inventory, More Time at the Bench? Yes Please
Industry InsightLab efficiency is critical to speeding up development processes, yet many researchers find they spend more time managing consumables data than working at the bench. Lab informatics is one solution to this problem.
Read More
Advancing ALS Research With Omics Analysis Technology
Industry InsightClinical trials produce a massive amount of medically relevant and highly sensitive data. Leveraging such data could make a difference to efforts to create more personalized, effective medicines. We talked to Medidata’s Sheila Diamond to find out more.
Read More
